Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
Details for Australian Patent Application No. 2006204792 (hide)
International Classifications
Event Publications
16 August 2007 PCT application entered the National Phase
PCT publication WO2006/076595 Priority application(s): WO2006/076595
29 November 2007 Change of Name(s) of Applicant(s), Section 104
Pharmacopeia Drug Discovery, Inc.; Signal Pharmaceuticals, Llc The name of the applicant has been changed to Pharmacopeia, Inc.; Signal Pharmaceuticals, Llc
3 January 2008 Alteration of Name
The name of the applicant has been altered to Pharmacopeia, Inc.; Signal Pharmaceuticals, LLC
17 March 2011 Application Accepted
Published as AU-B-2006204792
14 July 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006204813-Security features, their use, and processes for making them
2006204791-Antibodies and Fc fusion proteins with altered immunogenicity
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser